外周神经电刺激永久植入前是否需临时试验:多中心回顾性比较分析
这项多中心回顾性研究比较了慢性疼痛患者永久外周神经电刺激(PNS)植入前先进行临时试验(TTP)与直接永久植入(DTP)两种策略。共分析130例患者(TTP 54例,DTP 76例),6个月时TTP组疼痛缓解56.7%±27.9%,DTP组45.1%±33.6%,组间差异无统计学意义;阿片消耗量两组均下降且无差异。结论提示TTP策略并未带来更优的镇痛结局。
要点
- 6个月疼痛缓解率TTP组56.7%±27.9%,DTP组45.1%±33.6%,组间差异无统计学意义。
- 两组阿片消耗量(口服吗啡当量)6个月时均下降,组间无统计学差异。
- 装置取出率和不良事件谱在两种策略间相当。
核心结论
- 没有证据表明永久PNS植入前进行临时试验(TTP)较直接永久植入(DTP)具有更优的镇痛结局。
- 两种策略患者在6个月时均较PNS治疗前基线获得有临床意义的疼痛缓解。
研究设计与样本
- 多中心回顾性研究,纳入2014年1月1日至2024年1月1日七家主要学术机构中接受永久PNS植入治疗慢性疼痛的成人患者。
- 共分析130例患者,按临床策略分为TTP组(54例)和DTP组(76例)。
- 双主要结局为6个月时疼痛缓解和较任何PNS治疗前基线的阿片消耗量(口服吗啡当量)变化。
- 采用多变量Tobit回归分析(逐步法)识别6个月疼痛缓解的预测因素。
主要发现
- TTP组6个月患者报告的疼痛缓解百分比为56.7%±27.9%,DTP组为45.1%±33.6%。
- 6个月估计平均疼痛缓解百分比在TTP和DTP组间相似,组间差异15.24%(95%CI -0.32至30.80,p=0.052),多重插补敏感性分析结果一致。
- 阿片消耗量在TTP组下降(-3.1±9.9 mg)和DTP组下降(-2.1±8.1 mg)相似,组间无统计学差异(平均组间差异:-1.00,95%CI -4.57至2.57,p=0.580),敏感性分析结果一致。
- 装置取出率和不良事件谱在两组间相当。
临床怎么用
- 对于考虑永久PNS植入的慢性疼痛患者,DTP策略可作为TTP策略的合理替代,无需强制进行临时试验。
- 两种策略在6个月时均能获得有临床意义的疼痛缓解,选择应基于个体化评估。
局限性
- 回顾性研究设计可能存在选择偏倚和混杂因素。
- 样本量有限(共130例),组间疼痛缓解差异的95%CI上限接近无效线(p=0.052),需更大样本验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Peripheral nerve stimulation (PNS) is an emerging neuromodulation therapy for chronic pain, yet its use in clinical practice varies significantly. Although temporary PNS is widely incorporated, either as a screening trial or a treatment itself, the evidence supporting the use of temporary PNS prior to permanent implantation is limited. We aimed to compare pain relief, opioid consumption, and adverse events between an approach implementing temporary PNS before permanent implantation (temporary-to-permanent (TTP)) vs proceeding directly to permanent PNS implantation (direct-to-permanent (DTP)). METHODS: A multicenter retrospective study was undertaken at seven major academic institutions from January 1, 2014, to January 1, 2024. Adult patients who underwent permanent PNS implantation for the treatment of chronic pain conditions were included and were divided into TTP or DTP cohorts based on their clinical approach. The dual primary outcomes were pain relief and opioid consumption (in oral morphine equivalents) at 6 months compared with baseline before any PNS therapy. Multivariable Tobit regression analysis was performed to identify predictors of pain relief at 6 months using a stepwise approach. RESULTS: A total of 130 patients were analyzed (54 in TTP approach, 76 in DTP approach). Patient-reported percentage pain relief was 56.7%±27.9% at 6 months compared with baseline (before PNS implantation) in the TTP cohort, and 45.1%±33.6% in the DTP cohort. The estimated mean percentage pain relief at 6 months was similar in the TTP and DTP cohorts (between-group difference 15.24%; 95% CI -0.32 to 30.80, p=0.052), with consistent findings after sensitivity analysis with multiple imputation. Opioid consumption declined similarly in the TTP (-3.1±9.9 mg) and DTP (-2.1±8.1 mg) cohorts at 6 months with no statistical difference between cohorts (mean between-group difference: -1.00, 95% CI -4.57 to 2.57, p=0.580), and with consistent findings after sensitivity analysis. Device explantation rates and adverse event profiles were comparable between cohorts. CONCLUSION: Although temporary PNS is widely performed prior to permanent PNS implantation, there was no evidence that the TTP approach is associated with superior analgesic outcomes compared with the DTP approach. Further, patients in both approaches achieved clinically meaningful pain relief at 6 months compared with baseline status prior to PNS therapy.
引用
- D'Souza RS, Yu Y, Singh V, et al. To trial or not to trial before peripheral nerve stimulation for chronic pain: a retrospective multicenter comparative analysis of temporary-to-permanent and direct-to-permanent implantation approaches. Reg Anesth Pain Med. 2025. PMID: 40659443. doi:10.1136/rapm-2025-106734
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。